Clinical Trial Update: Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial (ECHO-CRC) is evaluating the circulating immune response after Histosonics in colorectal cancer and is currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Histosonics

Snippet

Sponsor: Northwell Health | Conditions: Colorectal (Colon or Rectal) Cancer | Phase 1 | Status: RECRUITING